Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Repaglinide, an oral hypoglycemic agent, is a short-acting insulin secretagogue. We describe a case, in which an extremely low dose of repaglinide caused severe hypoglycemia and novel drug interactions are suggested. A 71-year-old man with type 2 diabetes was taken to the hospital due to consciousne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetol Int
Autors principals: Komatsu, Hitomi, Enomoto, Mariko, Shiraishi, Hisashi, Morita, Yasuyo, Hashimoto, Daisuke, Nakayama, Shuichi, Funakoshi, Shogo, Hirano, Seiki, Terada, Yoshio, Miyamura, Mitsuhiko, Fujimoto, Shimpei
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538475/
https://ncbi.nlm.nih.gov/pubmed/33088647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00434-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars